Kv1.3
Meet in Italy for Life Sciences - Awards

We are happy and thrilled to announce that our Kv1.3 pitch was chosen as "Best Innovative Business Proposal" by a board of investors on Startup Breeding, an annual event of Cluster Nazionale Scienze della Vita ALISEI, the Italian National Cluster for Life Sciences.

Furthermore, we received the Special Awards of 2i3T - Innovative Companies Incubator of the University of Turin and Bioindustry Park Silvano Fumero S.p.A. Società Benefit.

Introduction
Link icon purple
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
WRITTEN BY
VRG Therapeutics
PUBLISHED ON
November 2, 2023
SHARE THIS ON
Linkedin purple icon share buttonFacebook purple icon share buttonX purple icon share button
Introduction
Link icon purple
Latest
News
The latest industry news, interviews, technologies, and resources.
View All News
Kv1.3
October 18, 2024
By VRG Therapeutics
Press release
White arrow icon up and right direction redirecting to Partner with US page
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
Latest
News
The latest industry news, interviews, technologies, and resources.
Kv1.3
October 18, 2024
By VRG Therapeutics
Press release
White arrow icon up and right direction redirecting to Partner with US page
Infrastructure
September 4, 2024
By VRG Therapeutics
VRG Therapeutics is expanding into the Netherlands!
White arrow icon up and right direction redirecting to Partner with US page
View All News
Learn More
Million ways to improve life
Learn More
Million ways to improve life